Jate Samathivathanachai ’01

Jate Samathivathanachai ’01 joined Foundery Innovations, an immunotherapeutics-focused venture fund and studio, as Chief Business Officer in December 2022. Foundery validates and develops early drug concepts to produce pre-IND candidate packages in collaboration with academic investigators that are spun-out into independent NewCos or out-licensed to industry partners for clinical development.